InsideArbitrage Event Driven Monitor – October 20, 2026

Note: You can click on any section title to jump straight to the related tool or page.

Merger Arbitrage

1. SLN: The acquisition of Silence Therapeutics plc (SLN) by Merck KGaA for a closing value of $1.10 billion. Silence shareholders will receive $20 in cash per American Depositary Share (ADS), with each ADS representing three ordinary shares of Silence (or $6.67 per ordinary share). The cash consideration represents a premium of 130.41% over the stock’s last close. (Press Release)
2. PERF: Perfect (PERF) announced that at an extraordinary general meeting, the shareholders voted in favor of the merger with ProjectNY.
3. SYNA: Synaptics (SYNA) filed a definitive proxy statement. The special meeting of shareholders will be held on November 17, 2026.

Only plus or premium subscribers can access this post. Subscribe today.